Next Article in Journal
Syntheses of Chiral 2-Oxazolines from Isosorbide Epoxide Derivative
Previous Article in Journal
6,6′-{[Ethane-1,2-diylbis(azaneylylidene)]bis(methaneylylidene)}bis[(1-oxyl-2,2,5,5-tetramethylpyrrolidine-3-carboxy)phenolato] Nickel(II)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

2-(Heptylthio)pyrimidine-4,6-diamine

1
Faculty of Chemistry, National University of Uzbekistan Named After Mirzo Ulugbek, 4 University Str., Tashkent 100174, Uzbekistan
2
Department of Chemistry, Graduate School and Faculty of Science, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan
*
Author to whom correspondence should be addressed.
Molbank 2025, 2025(1), M1965; https://doi.org/10.3390/M1965
Submission received: 21 January 2025 / Accepted: 5 February 2025 / Published: 6 February 2025
(This article belongs to the Section Organic Synthesis and Biosynthesis)

Abstract

:
Thiopyrimidines represent one of the most active classes of compounds, possessing a wide spectrum of biological activities. Herein, we report the synthesis of 2-(heptylthio)pyrimidine-4,6-diamine (HPDA) via S-alkylation. The structure of HPDA was elucidated using 1H and 13C nuclear magnetic resonance (NMR), heteronuclear multiple bond correlation (HMBC), high resolution mass (HRMS), and infrared (IR) spectroscopies.

1. Introduction

Heterocyclic compounds hold significant importance for the pharmaceutical industry, as many crucial life-science products contain them. Derivatives of pyrimidine show various biological activities [1] such as antidiabetic [2], anti-inflammatory [3], antitumor [4], antibacterial [5], antihypertensive [6], antifungal [7], antioxidant [8], and antitubercular [9]. Among these, diaminomercaptopyrimidine (DAMP) has a broad range of synthetic applications arisen from pyrimidine-conjugated amino and mercapto groups [10,11]. The structural feature of DAMP also facilitates cyclization reactions, leading to the formation of expanded heterocycles such as 5-(buthylthio)-3H-[1,2,3]-triazolo[4,5-d]pyrimidine-7-amine, 2-(buthylthio)-9-(4-nitrobenzyl)-9H-purine-6-amine, 2-butyloxy-9-(2,6-difluorobenzyl)-N-(morpholinoethyl)-9H-purine-6-amine (purine derivatives) [12], and 8-benzyl pteridine-6,7-diones [13]. Additionally, DAMP can undergo condensation reactions on its amino group(s) with carbonyl compounds to form Schiff bases [14]. On the other hand, the mercapto group of DAMP reacts with alkyl halides to form thioethers [10,15]. In this work, the heptylation of DAMP was examined to synthesize a novel S-alkylated derivative as one of the candidates to subject to our future drug discovery project.

2. Results and Discussion

A reaction of n-heptyl chloride with sodium salt of DAMP (1) in DMF at 50 °C furnished a single solid product (2) in 67% yield just by washing the crude material with water (Scheme 1). Although previous alkylation reactions of DAMP in the literature reported the formation of S-alkylated products [10,15,16,17], there were few pieces of spectroscopic evidence. Since there are three possible mono-alkylated products on a nitrogen or a sulfur atom (2, 3, and 4, respectively, Chart 1), the structure of our product was carefully elucidated by considerable spectroscopic analyses. First, an IR spectrum of compound 2 showed overlapped absorption bands at ν = 3470, 3320 and 3181 cm−1 which were assigned to the N-H stretching from two amino groups. It also indicated the existence of an alkyl sulfide moiety attached to the C2 atom in a pyrimidine ring by peaks at ν = 1076, 1236, and 1280 cm−1 (Figure S1) [18]. The HRMS (ESI-TOF) of the obtained compound showed m/z = 241.1500 which matched the calculated value for [M+H]+ ([C11H20N4S]+, 241.1481) (Figure S2). These results indicated that the mono-alkylation occurred onto the mercapto group of DAMP, but to obtain more robust evidence, we further analyzed NMR.
The 1H NMR spectrum of the isolated compound exhibited a triplet signal for the methyl group at the terminal position of the heptyl chain (H7′) at δ 0.87 ppm. Among fourteen methylene protons of the n-heptyl group, ten (H2′–H6′) resonated at δ 1.22–1.32, 1.36–1.41 and 1.60–1.65 ppm, while the two methylene protons next to a sulfur atom (H-1’) gave a triplet at δ 3.01 ppm. A singlet at δ 5.26 ppm corresponded to an aromatic proton (H5) on the pyrimidine ring (Figure S3).
In the 13C NMR spectrum, the terminal methyl carbon C7′ appeared at δ 13.2 ppm, and the methylene carbons C2′–C6′ resonated between δ 22.4 and 29.9 ppm, which were consistent with their aliphatic environment. The chemical shift of the carbon (C1′) adjacent to the sulfur atom showed a signal at δ 31.7 ppm, which is also consistent with the S-alkylation. In contrast, if compounds were N-alkylated products, it would exhibit the N-CH2- peak at around δ 43 ppm according to the literature [19]. The aromatic carbons were identified at δ 79.2 (C5), 163.8 (C4 and C6) [17] and 170.0 ppm (C2) [20], respectively (Figure S4). These assignments were also evidenced by COSY and HSQC experiments.
With the full assignment of 1H and 13C NMR in hand, we turned our attention to the unambiguous determination of the alkylation site via an HMBC experiment. Our careful analysis of the HMBC chart revealed significant cross peaks, that is, it provided the most critical 4JCH interaction between H1′ and C2, which confirmed the attachment of the alkyl group to the sulfur atom, consistent with the structure of 2 (Figure S5). As shown above, the combined spectral analyses firmly corroborate the structural assignment of compound 2 [21]. This selectivity might be explained by the so-called hard and soft acids and bases (HSAB) rules in which soft bases (such as sulfur anions) tend to react with soft acids (such as alkyl halides).

3. Materials and Methods

3.1. Instrumentation

IR spectrum was recorded on a JASCO FT/IR-4100. NMR spectra were recorded on a JEOL JNM-ECA 600 spectrometer. Chemical shifts are reported in ppm from tetramethysilane (TMS) with reference to an internal residual solvent [1H NMR: CD3OD (3.31); 13C NMR: CD3OD (47.3–48.1)]. The following abbreviations are used to designate the multiplicities: s = singlet, d = doublet, t = triplet, m = multiplet, br = broad. High resolution mass spectrum (HRMS) was recorded on a Bruker microTOFII.

3.2. 2-(Heptylthio)pyrimidine-4,6-diamine (2)

A three-necked round-bottomed flask, equipped with a thermometer, a reflux condenser and a magnetic stirrer was set up. DAMP (1, 50.0 mg, 0.351 mmol) was dissolved in a mixture of NaOH aq. (1.0 N, 0.35 mL, 0.35 mmol) and methanol (5.0 mL). The reaction mixture was stirred at room temperature for 1 h and evaporated to give a tan solid. To a solution of the tan solid in DMF (5.0 mL) was added n-heptyl chloride (0.050 mL, 0.35 mmol) and stirred at 50 °C for 16 h. After the completion of the reaction (as monitored by TLC), DMF was evaporated. The obtained residue was treated with water (50 mL) and extracted with chloroform (3 × 50 mL). The combined organic layer was dried over Na2SO4, filtered, evaporated under reduced pressure, and the residue was dried under vacuum to provide compound 2 as a brown amorphous solid (56.9 mg, 0.237 mmol, 67%, over 2 steps).
Rf = 0.62 (CHCl3/MeOH = 5/1); IR (neat), 3470, 3320, 3181, 1610, 1457, 1303, 1280, 1235, 1076, 974, 805, 668 cm−1; 1H NMR (600 MHz, CD3OD) δ: 0.87 (t, J = 12.0 Hz, 3H, H7′), 1.22–1.32 (m, 6H, H4′–6′), 1.36–1.41 (m, 2H, H3′), 1.60–1.65 (m, 2H, H2′), 3.01 (t, J = 7.8 Hz, 2H, H1′), 5.26 (s, 1H, H5) ppm; 13C NMR (150 MHz, CD3OD) δ: 13.2 (C7′), 22.4, 28.6, 28.8, 29.5, 29.9 (C2′–6′), 31.7 (C1′), 79.2 (C5), 163.8 (C4, C6), 170.0 (C2) ppm; HRMS (ESI-TOF) m/z [M+H]+ calcd for C11H20N4S = 241.1481, found 241.1500.

4. Conclusions

In conclusion, we have shown that S-heptylated 4,6-diamino-2-mercapto-pyrimidine (DAMP) (2) could be synthesized from the sodium salt of DAMP (1) with n-heptyl chloride in DMF. The structure of 2 was unambiguously elucidated using 1H-, 13C-, and HMBC-NMR, as well as HRMS, and IR spectroscopies to find the alkylation mainly occurred on a sulfur atom, probably because of the HSAB rules. Biological assays of 2 are now underway in our laboratory.

Supplementary Materials

The following supporting information for the characterization of 2 can be downloaded online: Molfile of Compound 2; Figure S1: IR spectrum; Figure S2: HRMS (ESI-TOF) spectrum; Figure S3: 1H NMR spectrum (600 MHz, CD3OD); Figure S4: 13C NMR spectrum (150 MHz, CD3OD); Figure S5: HMBC spectrum (CD3OD).

Author Contributions

Conceptualization, G.S.; methodology, G.S.; validation, G.S., M.U. and K.T.; formal analysis, G.S., M.U. and K.T.; investigation, G.S. and M.U.; resources, K.T. and T.K.; data curation, G.S., M.U., K.T. and T.K.; writing—original draft preparation, G.S., M.U. and T.K.; writing—review and editing, K.T.; visualization, G.S. and M.U.; supervision, T.K.; project administration, T.K.; funding acquisition, K.T. and T.K. All authors have read and agreed to the published version of the manuscript.

Funding

This work was partially supported by Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA) as a Science and Technology Research Partnership for Sustainable Development (SATREPS, JPMJSA2306) project (Japan) to K.T.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors on request.

Acknowledgments

We are grateful to the Bioorganic Chemistry Laboratory (Department of Chemistry, Faculty of Science, Kyushu University, Japan) for providing us with access to HRMS and IR devices. We also thank Alimjan Matchanov (National University of Uzbekistan) for invaluable discussion and Sardorbek Otajonov (National University of Uzbekistan) for his personal donation to this project. M.U. thanks Scholarship Program to Study in Japan from Konosuke Matsushita Foundation (Japan).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Naik, T.A.; Chikhalia, K.H. Studies on synthesis of pyrimidine derivatives and their pharmacological evaluation. J. Chem. 2007, 4, 60–66. [Google Scholar] [CrossRef]
  2. Bhosle, M.R.; Deshmukh, A.R.; Pal, S.; Srivastava, A.K.; Mane, R.A. Synthesis of new thiazolylmethoxyphenyl pyrimidines and antihyperglycemic evaluation of the pyrimidines, analogues isoxazolines and pyrazolines. Bioorg. Med. Chem. Lett. 2015, 25, 2442–2446. [Google Scholar] [CrossRef] [PubMed]
  3. Keche, A.P.; Hatnapure, G.D.; Tale, R.H.; Rodge, A.H.; Birajdar, S.S.; Kamble, V.M. A novel pyrimidine derivatives with aryl urea, thiourea and sulfonamide moieties: Synthesis, anti-inflammatory and antimicrobial evaluation. Bioorg. Med. Chem. Lett. 2012, 22, 3445–3448. [Google Scholar] [CrossRef] [PubMed]
  4. Chu, X.J.; DePinto, W.; Bartkovitz, D.; So, S.S.; Vu, B.T.; Packman, K.; Lukacs, C.; Ding, Q.; Jiang, N.; Wang, K.; et al. Discovery of [4-amino-2-(1-methanesulfonylpiperidin-4-ylamino) pyrimidin-5-yl](2, 3-difluoro-6-methoxyphenyl) methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity. J. Med. Chem. 2006, 49, 6549–6560. [Google Scholar] [CrossRef] [PubMed]
  5. Suresh, L.; Kumar, P.S.V.; Poornachandra, Y.; Kumar, C.G.; Chandramouli, G.V.P. Design, synthesis and evaluation of novel pyrazolo-pyrimido[4,5-d] pyrimidine derivatives as potent antibacterial and biofilm inhibitors. Bioorg. Med. Chem. Lett. 2017, 27, 1451–1457. [Google Scholar] [CrossRef] [PubMed]
  6. Alam, O.; Khan, S.A.; Siddiqui, N.; Ahsan, W.; Verma, S.P.; Gilani, S.J. Antihypertensive activity of newer 1,4-dihydro-5-pyrimidine carboxamides: Synthesis and pharmacological evaluation. Eur. J. Med. Chem. 2010, 45, 5113–5119. [Google Scholar] [CrossRef] [PubMed]
  7. Zhang, J.; Peng, J.F.; Bai, Y.B.; Wang, P.; Wang, T.; Gao, J.M.; Zhang, Z.T. Synthesis of pyrazolo[1,5-a]pyrimidine derivatives and their antifungal activities against phytopathogenic fungi in vitro. Mol. Diversity. 2016, 20, 887–896. [Google Scholar] [CrossRef] [PubMed]
  8. Baharfar, R.; Azimi, R. Sulfanilic acid functionalized mesoporous SBA-15: A water-tolerant solid acid catalyst for the synthesis of uracil fused spirooxindoles as antioxidant agents. J. Chem. Sci. 2015, 127, 1389–1395. [Google Scholar] [CrossRef]
  9. Chitre, T.S.; Kathiravan, M.K.; Chothe, A.S.; Rakholiya, V.K.; Asgaonkar, K.D.; Shital, M. Synthesis and Antitubercular activity of some substituted pyrimidine derivatives. J. Pharm. Res. 2011, 4, 1882–1883. [Google Scholar]
  10. Mohebbi, S.; Falcón-Pérez, J.M.; González, E.; Millet, O.; Mato, J.M.; Kobarfard, F. Synthesis, dihydrofolate reductase inhibition, anti-proliferative testing, and saturation transfer difference 1H-NMR study of some new 2-substituted-4, 6-diaminopyrimidine derivatives. Chem. Pharm. Bull. 2012, 60, 70–78. [Google Scholar] [CrossRef] [PubMed]
  11. Baddar, F.G.; Al-Hajjar, F.H.; El-Rayyes, N.R. Acetylenic ketones. Part V. Reaction of acetylenic ketones with thiourea an some of its derivatives. J. Hetrocycl. Chem. 1977, 14, 367. [Google Scholar] [CrossRef]
  12. Geng, B.; Breault, G.; Comita-Prevoir, J.; Petrichko, R.; Eyermann, C.; Lundqvist, T.; Noonan, B. Exploring 9-benzyl purines as inhibitors of glutamate racemase (MurI) in Gram-positive bacteria. Bioorg. Med. Chem. Lett. 2008, 18, 4368–4372. [Google Scholar] [CrossRef] [PubMed]
  13. Breault, G.A.; Comita-Prevoir, J.; Eyermann, C.J.; Geng, B.; Petrichko, R.; Doig, P.; Noonan, B. Exploring 8-benzyl pteridine-6, 7-diones as inhibitors of glutamate racemase (MurI) in gram-positive bacteria. Bioorg. Med. Chem. Lett. 2008, 18, 6100–6103. [Google Scholar] [CrossRef] [PubMed]
  14. Raghavan, S.C.; Srivastava, M.; Karki, S.S.; Choudhary, B. Compounds as Inhibitor of DNA Double-Strand Break Repair, Methods and Applications Thereof. U.S. Patent 9,969,696 B2, 15 May 2018. [Google Scholar]
  15. Zhang, Q.; Xia, Z.; Mitten, M.J.; Lasko, L.M.; Klinghofer, V.; Bouska, J.; Vasudevan, A. Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitors. Bioorg. Med. Chem. Lett. 2012, 22, 7615–7622. [Google Scholar] [CrossRef] [PubMed]
  16. Aktan, E.; Babür, B.; Seferoğlu, N.; Çatıkkaş, B.; Kaynak, F.B.; Seferoğlu, Z. Combined spectroscopic, XRD crystal structure and DFT studies on 2-(ethylthio) pyrimidine-4, 6-diamine. J. Mol. Struct. 2017, 1145, 152–159. [Google Scholar] [CrossRef]
  17. Nguyen, H.N.; Bregman, H.; Buchanan, J.L.; Du, B.; Feric, E.; Huang, L.; DiMauro, E.F. Discovery and optimization of aminopyrimidinones as potent and state-dependent Nav1. 7 antagonists. Bioorg. Med. Chem. Lett. 2012, 22, 1055–1060. [Google Scholar] [CrossRef] [PubMed]
  18. Fargualy, A.M.; Habib, N.S.; Ismail, K.A.; Hassan, A.M.M.; Sarg, M.T.M. Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives. Eur. J. Med. Chem. 2013, 66, 276–295, The C2-S7-C1′ moiety in a 2-(alkylthio)pyrimidine derivative gave peaks at 1081–1085 and 1255–1266 cm−1. [Google Scholar] [CrossRef] [PubMed]
  19. Liu, G.; Xu, J.; Yu, M.; Chen, N.; Zhang, S.; Ding, Z.; Du, H. New Approach to Synthesize Symmetrical and Unsymmetrical 6-(N-Alkyl (Aryl) Amino)-and 6-(N, N-Dialkyl (Aryl) Amino)-2, 4-Bis (Alkyl (Aryl) Thio) Pyrimidines as anti-Platelet Agents. Phosphorus Sulfur Silicon Relat. Elem. 2012, 187, 650–659. [Google Scholar] [CrossRef]
  20. Severina, H.; Skupa, O.; Khairulin, A.; Voloshchuk, N.; Georgiyants, V. Synthesis and anticonvulsant activity of 6-methyl-2-thioxo-2, 3-dihydropyrimidin-4 (1H)-one acetamides. J. Appl. Pharm. Sci. 2019, 9, 12–19. [Google Scholar]
  21. In the HMBC spectrum, a significant correlation was observed between the H1′ and C2 (compound 2 in Chart 1). Conversely, to support the potential N-alkylated products (3 and 4), an HMBC correlation between H1′ and C4 should be observed. However, it was not detectable on our HMBC chart (as shown in Chart 1). Though we are aware that unobservability cannot be positive evidence for the structure determination of an organic compound by NMR, we utilized this passive fact for our better speculation.
Scheme 1. S-Heptylation of 4,6-diamino-2-mercaptopyrimidine.
Scheme 1. S-Heptylation of 4,6-diamino-2-mercaptopyrimidine.
Molbank 2025 m1965 sch001
Chart 1. Structures of possible mono-alkylated compounds.
Chart 1. Structures of possible mono-alkylated compounds.
Molbank 2025 m1965 ch001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Salieva, G.; Uktamova, M.; Torikai, K.; Kholikov, T. 2-(Heptylthio)pyrimidine-4,6-diamine. Molbank 2025, 2025, M1965. https://doi.org/10.3390/M1965

AMA Style

Salieva G, Uktamova M, Torikai K, Kholikov T. 2-(Heptylthio)pyrimidine-4,6-diamine. Molbank. 2025; 2025(1):M1965. https://doi.org/10.3390/M1965

Chicago/Turabian Style

Salieva, Gulrukh, Malokhat Uktamova, Kohei Torikai, and Tursunali Kholikov. 2025. "2-(Heptylthio)pyrimidine-4,6-diamine" Molbank 2025, no. 1: M1965. https://doi.org/10.3390/M1965

APA Style

Salieva, G., Uktamova, M., Torikai, K., & Kholikov, T. (2025). 2-(Heptylthio)pyrimidine-4,6-diamine. Molbank, 2025(1), M1965. https://doi.org/10.3390/M1965

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop